leisure time -WSS

leisure time

author：comprehensive 2025-09-06 03:32:46 - browse：1892

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Medicare proceeds with plan to claw back hospital funds

hotspot

WSS

Extensive review finds private equity owners jack up cost of care

Telehealth startups are trying to fill the menopause care vacuum

Sarepta Duchenne therapy fails to meet primary endpoint in trial

The health care issue Democrats can’t solve: hospital reform

A new ‘biological computer' targets cancer while sparing healthy cells

When a patient nears the end, a feared therapy can comfort

hotspot

leisure time

explore

Tori Bowie and the unacceptable rates of Black maternal death

Judge denies Trump's request for new trial in E. Jean Carroll case

Supreme Court strikes down use of affirmative action

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

The cancer drug shortage isn’t new — and neither are the solutions

Medicare proceeds with plan to claw back hospital funds

At least 13 dead in Texas as scorching temps continue

'CMA Fest' 2023: How to watch, who is performing and more

Novavax promises a turnaround & Lilly roils the obesity market

Kidney transplant patients stopped immunosuppressants in trial

Wikipedia

The stock market has soared this year, but will it last? Experts weigh in

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Medicare proceeds with plan to claw back hospital funds

Sanders wants to replace patents with prizes for drug inventions

Telehealth startups are trying to fill the menopause care vacuum

hotspot

focus

focus

knowledge